Package Leaflet: Information for the User
Xariva 10 mg Hard Capsules EFG
rivaroxaban
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Xariva contains the active substance rivaroxaban and is used in adults to:
Xariva belongs to a group of medicines called antithrombotic agents. It works by blocking a factor involved in blood clotting (factor Xa) and thus reducing the tendency of blood to form clots.
Do not takeXariva
Do not take Xariva and inform your doctorif any of these apply to you.
Warnings and precautions
Talk to your doctor or pharmacist before taking this medicine.
Be particularly careful withXariva
Tell your doctor if you have any of these conditionsbefore taking this medicine. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If you need to have surgery
Children and adolescents
This medicine is not recommended for children under 18 years. There is not enough information on its use in children and adolescents.
Other medicines and Xariva
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
If any of the above applies to you, tell your doctorbefore taking this medicine, as the effect of rivaroxaban may be increased. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing stomach or intestinal ulcers, they will recommend that you also use a treatment to prevent ulcers.
If any of the above applies to you, tell your doctorbefore taking this medicine, as the effect of rivaroxaban may be reduced. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
Pregnancy and breastfeeding
Do not take rivaroxaban if you are pregnant or breastfeeding. If there is a possibility that you may become pregnant, use a reliable contraceptive while taking rivaroxaban. If you become pregnant while taking this medicine, tell your doctor immediately, who will decide how you should be treated.
Driving and using machines
This medicine may cause dizziness (a common side effect) or fainting (an uncommon side effect) (see section 4, "Possible side effects"). You should not drive, ride a bicycle, or use tools or machines if you are affected by these symptoms.
Xariva contains lactose and sodium
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per capsule; this is essentially "sodium-free".
Follow exactly the instructions for taking this medicine as indicated by your doctor. If you are unsure, consult your doctor or pharmacist again.
What dose to take
The recommended dose is one rivaroxaban 10 mg capsule once a day.
After at least 6 months of treatment for blood clots, the recommended dose is one 10 mg capsule once a day or one 20 mg capsule once a day. Your doctor has prescribed rivaroxaban 10 mg once a day.
Swallow the capsule, preferably with water.
Rivaroxaban can be taken with or without food.
If you have difficulty swallowing the capsule whole, consult your doctor about other ways to take rivaroxaban. The contents of the capsule can be mixed with water or apple sauce, immediately before taking it.
If necessary, your doctor may also administer the contents of the capsule of this medicine dissolved through a gastric tube.
When to take Xariva
Take this medicine every day, until your doctor tells you to stop.
Try to take this medicine at the same time every day, to help you remember.
Your doctor will decide how long you should continue taking the treatment.
To prevent the formation of blood clots in the veins after hip or knee replacement surgery:
Take the first dose 6 to 10 hours after the operation.
If you have had major hip surgery, you will usually take rivaroxaban for 5 weeks.
If you have had major knee surgery, you will usually take rivaroxaban for 2 weeks.
If you take more Xariva than you should
Call your doctor immediately if you have taken too many rivaroxaban capsules. Taking too much rivaroxaban increases the risk of bleeding.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Xariva
If you forget to take a dose, take it as soon as you remember. Take the next dose the following day and, after that, take one capsule every day, as usual.
Do not take a double dose to make up for forgotten doses.
If you stop taking Xariva
Do not stop taking rivaroxaban without talking to your doctor first, as rivaroxaban prevents the development of a serious condition.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, rivaroxaban can cause side effects, although not everybody gets them.
Like other similar medicines to reduce blood clotting, rivaroxaban can cause bleeding, which can be life-threatening. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be visible.
Tell your doctor immediately if you experience any of the following side effects:
Your doctor will decide whether to keep you under closer observation or modify your treatment.
The frequency of these side effects is very rare (up to 1 in 10,000 people).
The frequency of severe allergic reactions is very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible side effects:
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very rare(may affect up to 1 in 10,000 people):
Frequency not known(cannot be estimated from available data):
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on each blister, after "CAD" or "EXP". The expiry date is the last day of the month indicated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition ofXariva
Capsule content:lactose monohydrate, microcrystalline cellulose, sodium croscarmellose, hypromellose, sodium laurilsulfate, and magnesium stearate;
Capsule shell:gelatin, titanium dioxide (E-171), yellow iron oxide (E-172), red iron oxide (E-172), and black iron oxide (E-172).
Appearance of the Product and Package Contents
The hard capsules of Xariva 10 mg are 15.9 mm in length (size "3") with opaque cap and body of beige color.
Xariva 10 mg is available in packs of 30 hard capsules in PVC/PVdC - aluminum blister packs.
Marketing Authorization Holder
Kern Pharma, S.L.
Venus, 72 - Pol. Ind. Colón II
08228 Terrassa, Barcelona
Spain
Manufacturer
Zentiva, S.A.
B-dul Theodor Pallady nr.50, sector 3,
Bucharest, 032266,
Romania
or
Pharmadox Healthcare Ltd.
KW20A Kordin Industrial Park,
Paola, PLA3000,
Malta
Date of the Last Revision of this Leaflet:May 2024
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/